CSS LLC’s Aptose Biosciences, Inc. APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-222
Closed -$74K 1258
2022
Q2
$74K Hold
222
﹤0.01% 917
2022
Q1
$136K Hold
222
﹤0.01% 901
2021
Q4
$135K Buy
+222
New +$209K ﹤0.01% 971
2021
Q3
Sell
-87
Closed -$129K 1357
2021
Q2
$129K Sell
87
-10
-10% -$21.8K 0.01% 913
2021
Q1
$261K Buy
+97
New +$192K 0.01% 712
2020
Q4
Sell
-24
Closed -$64K 975
2020
Q3
$64K Sell
24
-13
-35% -$32.4K ﹤0.01% 696
2020
Q2
$104K Buy
37
+12
+48% +$38.7K 0.01% 546
2020
Q1
$67K Sell
25
-160
-86% -$477K 0.01% 520
2019
Q4
$472K Buy
+185
New +$241K 0.03% 365

Other funds holding APTO

CSS LLC's APTO Position: Q3 2021 in Review

CSS LLC sold out of Aptose Biosciences, Inc. (APTO) in Q3 2021, closing a stake of 3 shares — an estimated $5K sold.

CSS LLC first reported a position in APTO in Q1 2020 and held it in 5 quarters. The position peaked at $254K in Q3 2020. 64 funds tracked by Wall St. Rank hold APTO as of Q3 2021.

  • CSS LLC reported no remaining Aptose Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • CSS LLC sold 3 Aptose Biosciences, Inc. shares in Q3 2021, an estimated $5K.
  • CSS LLC first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 5 quarters.
  • CSS LLC's Aptose Biosciences, Inc. position peaked at $254K in Q3 2020.
  • 64 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2021.

Based on CSS LLC's 13F filing for Q3 2021, filed 15 Nov 2021.